2020 ACP临床指南:成年男性年龄相关性低睾酮水平的睾酮治疗

2020-01-07 美国医师协会 Ann Intern Med. 2020 Jan 7.

2020年1月,美国医师协会(ACP)发布了成年男性年龄相关性低睾酮水平的睾酮治疗指南,ACP专家组主要基于当前最新的证据针对成年男性年龄相关性低睾酮水平的睾酮治疗提出指导建议。 2020年1月,美国医师协会(ACP)发布了成年男性年龄相关性低睾酮水平的睾酮治疗指南,ACP专家组主要基于当前最新的证据针对成年男性年龄相关性低睾酮水平的睾酮治疗提出指导建议。

中文标题:

2020 ACP临床指南:成年男性年龄相关性低睾酮水平的睾酮治疗

英文标题:

Testosterone Treatment in Adult Men With Age-Related Low Testosterone: A Clinical Guideline From the American College of Physicians.

发布机构:

美国医师协会

发布日期:

2020-01-07

简要介绍:

2020年1月,美国医师协会(ACP)发布了成年男性年龄相关性低睾酮水平的睾酮治疗指南,ACP专家组主要基于当前最新的证据针对成年男性年龄相关性低睾酮水平的睾酮治疗提出指导建议。

 

拓展指南:睾酮相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2020 ACP临床指南:成年男性年龄相关性低睾酮水平的睾酮治疗)] GetToolGuiderByIdResponse(projectId=1, id=9383c1c00185e6b8, title=2020 ACP临床指南:成年男性年龄相关性低睾酮水平的睾酮治疗, enTitle=Testosterone Treatment in Adult Men With Age-Related Low Testosterone: A Clinical Guideline From the American College of Physicians., guiderFrom=Ann Intern Med. 2020 Jan 7., authorId=null, author=, summary=2020年1月,美国医师协会(ACP)发布了成年男性年龄相关性低睾酮水平的睾酮治疗指南,ACP专家组主要基于当前最新的证据针对成年男性年龄相关性低睾酮水平的睾酮治疗提出指导建议。 2020年1月,美国医师协会(ACP)发布了成年男性年龄相关性低睾酮水平的睾酮治疗指南,ACP专家组主要基于当前最新的证据针对成年男性年龄相关性低睾酮水平的睾酮治疗提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=146, associationName=美国医师协会, associationIntro=美国医师协会(ACP,American College of Physicians)成立于1915年,是美国最大的医学专业协会。它的宗旨是通过在医师中间培养高超的行业水平和职业的医学道德来促进国民的健康水平。官方期刊《内科学年鉴》创刊于1927年,是内科学研究方面的国际顶尖期刊。此刊旨在促进内科的临床实践水平。, copyright=0, guiderPublishedTime=Tue Jan 07 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年1月,美国医师协会(ACP)发布了成年男性年龄相关性低睾酮水平的睾酮治疗指南,ACP专家组主要基于当前最新的证据针对成年男性年龄相关性低睾酮水平的睾酮治疗提出指导建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>睾酮</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=b669b1c001e90a12" title="2019 全球共识立场声明:睾酮疗法在女性中的应用" target=_blank>2019 全球共识立场声明:睾酮疗法在女性中的应用</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=32f411c0015e666c" title="2018 AUA指南:睾酮素缺乏症的评估和管理" target=_blank>2018 AUA指南:睾酮素缺乏症的评估和管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5d84c1c0015e1971" title="2018 TES临床实践指南:睾酮治疗男性性腺功能减退" target=_blank>2018 TES临床实践指南:睾酮治疗男性性腺功能减退</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c8fce1c0012e08e4" title="2016 ESA立场声明:男性性功能减退症的评估和睾酮治疗的适应症" target=_blank>2016 ESA立场声明:男性性功能减退症的评估和睾酮治疗的适应症</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6f02e1c000e9a97f" title="2010 ENDO/CDC共识声明:改进睾酮测定方法" target=_blank>2010 ENDO/CDC共识声明:改进睾酮测定方法</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%9D%BE%E9%85%AE" target=_blank>有关睾酮更多指南</a></ul>, tagList=[TagDto(tagId=99166, tagName=年龄相关性低睾酮), TagDto(tagId=14942, tagName=睾酮治疗)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4106, appHits=138, showAppHits=2, pcHits=2060, showPcHits=2838, likes=46, shares=8, comments=6, approvalStatus=1, publishedTime=Thu Jan 30 01:45:01 CST 2020, publishedTimeString=2020-01-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jan 30 01:45:01 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 01:26:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 ACP临床指南:成年男性年龄相关性低睾酮水平的睾酮治疗)])
2020 ACP临床指南:成年男性年龄相关性低睾酮水平的睾酮治疗
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=910692, encodeId=2b71910692ca, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201224/667cc4a41d3649699115f4285072c0b5/b20a1cdb1b1c4e34b2a6fe619b783822.jpg, createdBy=bdf25446651, createdName=ms6000000673753603, createdTime=Thu Dec 24 20:34:46 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908211, encodeId=ce11908211ee, content=有了中文版更方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201215/b7de2f779b7649f59625fe61b00dd508/32019f0e775847ba835ddbc4d4a97889.jpg, createdBy=81d25437156, createdName=Yixuesheng123, createdTime=Tue Dec 15 16:11:28 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883470, encodeId=8d738834e0de, content=Yes , beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43ab5416526, createdName=ms3000001494501499, createdTime=Tue Sep 08 05:37:48 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379109, encodeId=7e373e910929, content=日常学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dc05268402, createdName=148193d7m29(暂无昵称), createdTime=Tue Feb 11 10:15:34 CST 2020, time=2020-02-11, status=1, ipAttribution=)]
    2020-12-24 ms6000000673753603

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=910692, encodeId=2b71910692ca, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201224/667cc4a41d3649699115f4285072c0b5/b20a1cdb1b1c4e34b2a6fe619b783822.jpg, createdBy=bdf25446651, createdName=ms6000000673753603, createdTime=Thu Dec 24 20:34:46 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908211, encodeId=ce11908211ee, content=有了中文版更方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201215/b7de2f779b7649f59625fe61b00dd508/32019f0e775847ba835ddbc4d4a97889.jpg, createdBy=81d25437156, createdName=Yixuesheng123, createdTime=Tue Dec 15 16:11:28 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883470, encodeId=8d738834e0de, content=Yes , beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43ab5416526, createdName=ms3000001494501499, createdTime=Tue Sep 08 05:37:48 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379109, encodeId=7e373e910929, content=日常学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dc05268402, createdName=148193d7m29(暂无昵称), createdTime=Tue Feb 11 10:15:34 CST 2020, time=2020-02-11, status=1, ipAttribution=)]
    2020-12-15 Yixuesheng123

    有了中文版更方便

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=910692, encodeId=2b71910692ca, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201224/667cc4a41d3649699115f4285072c0b5/b20a1cdb1b1c4e34b2a6fe619b783822.jpg, createdBy=bdf25446651, createdName=ms6000000673753603, createdTime=Thu Dec 24 20:34:46 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908211, encodeId=ce11908211ee, content=有了中文版更方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201215/b7de2f779b7649f59625fe61b00dd508/32019f0e775847ba835ddbc4d4a97889.jpg, createdBy=81d25437156, createdName=Yixuesheng123, createdTime=Tue Dec 15 16:11:28 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883470, encodeId=8d738834e0de, content=Yes , beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43ab5416526, createdName=ms3000001494501499, createdTime=Tue Sep 08 05:37:48 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379109, encodeId=7e373e910929, content=日常学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dc05268402, createdName=148193d7m29(暂无昵称), createdTime=Tue Feb 11 10:15:34 CST 2020, time=2020-02-11, status=1, ipAttribution=)]
    2020-09-08 ms3000001494501499

    Yes

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=910692, encodeId=2b71910692ca, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201224/667cc4a41d3649699115f4285072c0b5/b20a1cdb1b1c4e34b2a6fe619b783822.jpg, createdBy=bdf25446651, createdName=ms6000000673753603, createdTime=Thu Dec 24 20:34:46 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908211, encodeId=ce11908211ee, content=有了中文版更方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201215/b7de2f779b7649f59625fe61b00dd508/32019f0e775847ba835ddbc4d4a97889.jpg, createdBy=81d25437156, createdName=Yixuesheng123, createdTime=Tue Dec 15 16:11:28 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883470, encodeId=8d738834e0de, content=Yes , beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43ab5416526, createdName=ms3000001494501499, createdTime=Tue Sep 08 05:37:48 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379109, encodeId=7e373e910929, content=日常学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dc05268402, createdName=148193d7m29(暂无昵称), createdTime=Tue Feb 11 10:15:34 CST 2020, time=2020-02-11, status=1, ipAttribution=)]
    2020-02-11 148193d7m29(暂无昵称)

    日常学习一下

    0